Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 5.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
34 priced months, Sep 2023 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
46.2% now, 48.0% in Sep 2025 · highest 59.3%, lowest 44.3%
Companies held
44 now, 41 in Sep 2025 · largest single holding 8.1% of equity
How it trades: leans toward adding to shares that fell over the previous six months (score -0.19 over 29 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- HDFC Pharma and Healthcare FundHDFC · 23 shared56.1%
- Bandhan BSE Healthcare Index FundBandhan · 42 shared55.7%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 42 shared55.7%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared54.6%
- NIPPON INDIA PHARMA FUNDNippon India · 22 shared53.9%
- Mirae Asset Healthcare FundMirae Asset · 19 shared53.7%
- ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 27 shared51.7%
- EODWHFEdelweiss · 18 shared50.6%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
- None this month.
Largest increases
- 01 Cohance Lifesciences Limited+28.6% +2.00 L
- 02 Dr. Reddy's Laboratories Limited+34.0% +1.54 L
- 03 Blue Jet Healthcare Limited+51.8% +1.28 L
- 04 Biocon Limited+25.5% +1.27 L
- 05 Jupiter Life Line Hospitals Limited+11.0% +1.17 L
- 06 Laxmi Dental Limited+10.5% +76,036
- 07 Alembic Pharmaceuticals Limited+21.4% +42,802
- 08 Global Health Limited+13.0% +35,710
- 09 Gland Pharma Limited+8.1% +15,000
- 10 Alkem Laboratories Limited+15.2% +13,500
Largest reductions
- 01 Anthem Biosciences Limited-29.1% -1.23 L
- 02 Sai Life Sciences Limited-33.4% -59,302
- 03 Emcure Pharmaceuticals Limited-78.3% -54,279
- 04 Sudeep Pharma Limited-10.6% -17,961
- 05 Caplin Point Laboratories Limited-9.0% -15,789
- 06 IPCA Laboratories Limited-0.6% -1,276
- 07 Windlas Biotech Limited-0.2% -463
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 8.10% | 109 Cr | 0.06 Cr | by Sep 2023 (34 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 6.54% | 88.00 Cr | 94,707 | by Sep 2023 (34 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 5.56% | 74.86 Cr | 0.06 Cr | by Sep 2023 (34 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 5.11% | 68.80 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 4.31% | 57.99 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 3.93% | 52.93 Cr | 0.01 Cr | by Sep 2023 (34 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 3.22% | 43.28 Cr | 53,000 | by Sep 2023 (34 mo+) |
| Caplin Point Laboratories Limited | Healthcare | Small Cap | 3.21% | 43.20 Cr | 0.02 Cr | Jan 2024 (32 mo) |
| Global Health Limited | Healthcare | Mid Cap | 3.14% | 42.31 Cr | 0.03 Cr | Oct 2024 (24 mo) |
| Lupin Limited | Healthcare | Mid Cap | 3.07% | 41.38 Cr | 0.02 Cr | Feb 2025 (20 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.99% | 40.23 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 2.97% | 39.98 Cr | 0.04 Cr | Mar 2024 (30 mo) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 2.97% | 39.96 Cr | 0.09 Cr | by Sep 2023 (34 mo+) |
| Marksans Pharma Limited | Healthcare | Small Cap | 2.39% | 32.23 Cr | 0.10 Cr | Nov 2023 (33 mo) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 2.34% | 31.54 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.25% | 30.25 Cr | 0.01 Cr | Mar 2024 (30 mo) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 2.22% | 29.84 Cr | 0.12 Cr | by Sep 2023 (34 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 2.20% | 29.57 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.15% | 28.88 Cr | 0.04 Cr | by Sep 2023 (34 mo+) |
| Procter & Gamble Health Limited | Healthcare | Small Cap | 2.07% | 27.82 Cr | 50,000 | by Sep 2023 (34 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 1.91% | 25.76 Cr | 0.03 Cr | Jul 2025 (15 mo) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 1.86% | 25.10 Cr | 0.04 Cr | Mar 2024 (30 mo) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 1.77% | 23.88 Cr | 0.01 Cr | Oct 2025 (12 mo) |
| Biocon Limited | Healthcare | Mid Cap | 1.72% | 23.14 Cr | 0.06 Cr | Jun 2025 (16 mo) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 1.56% | 20.96 Cr | 0.04 Cr | by Sep 2023 (34 mo+) |
| Windlas Biotech Limited | Not classified | Small Cap | 1.51% | 20.29 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Cipla Limited | Healthcare | Large Cap | 1.50% | 20.19 Cr | 0.01 Cr | by Sep 2023 (34 mo+) |
| Blue Jet Healthcare Limited | Healthcare | Small Cap | 1.50% | 20.18 Cr | 0.04 Cr | Jul 2026 (3 mo) |
| Alembic Pharmaceuticals Limited | Not classified | Small Cap | 1.49% | 20.04 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Viyash Scientific Limited | Healthcare | Small Cap | 1.47% | 19.85 Cr | 0.08 Cr | by Sep 2023 (34 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 1.41% | 19.02 Cr | 0.01 Cr | Feb 2024 (31 mo) |
| Sudeep Pharma Limited | Chemicals | Small Cap | 1.36% | 18.33 Cr | 0.02 Cr | Nov 2025 (11 mo) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 1.34% | 18.01 Cr | 0.01 Cr | Dec 2024 (22 mo) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 1.20% | 16.09 Cr | 0.01 Cr | by Sep 2023 (34 mo+) |
| Laxmi Dental Limited | Not classified | Small Cap | 1.14% | 15.38 Cr | 0.08 Cr | Jan 2025 (21 mo) |
| Manipal Health Enterprises Limited | Not classified | — | 1.12% | 15.05 Cr | 0.02 Cr | Aug 2026 (2 mo) |
| Aarti Pharmalabs Limited | Healthcare | Small Cap | 1.06% | 14.31 Cr | 0.01 Cr | Jan 2026 (9 mo) |
| Pfizer Limited | Healthcare | Small Cap | 0.99% | 13.30 Cr | 34,332 | by Sep 2023 (34 mo+) |
| Orchid Pharma Limited | Not classified | Small Cap | 0.75% | 10.11 Cr | 0.01 Cr | Nov 2023 (33 mo) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 0.71% | 9.61 Cr | 25,262 | Sep 2024 (25 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.69% | 9.23 Cr | 89,675 | Oct 2024 (24 mo) |
| Indegene Limited | Healthcare | Small Cap | 0.53% | 7.10 Cr | 0.01 Cr | Sep 2026 (1 mo) |
| Syngene International Limited | Healthcare | Small Cap | 0.44% | 5.96 Cr | 0.02 Cr | by Sep 2023 (34 mo+) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 0.22% | 2.91 Cr | 15,000 | Aug 2024 (26 mo) |
Half of its current holdings have been held for 33 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Cohance Lifesciences Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Blue Jet Healthcare Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Biocon Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Anthem Biosciences Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Indegene Limited | Sep 2026 | ▲ New position | +0.01 Cr |
| Jupiter Life Line Hospitals Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Laxmi Dental Limited | Sep 2026 | ▲ Increasing | +76,036 |
| Sai Life Sciences Limited | Sep 2026 | ▼ Reducing | -59,302 |
| Emcure Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -54,279 |
| Alembic Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +42,802 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +35,710 |
| Sudeep Pharma Limited | Sep 2026 | ▼ Reducing | -17,961 |
| Caplin Point Laboratories Limited | Sep 2026 | ▼ Reducing | -15,789 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +15,000 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +13,500 |
| Rainbow Childrens Medicare Limited | Sep 2026 | ▲ Increasing | +10,000 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -1,276 |
| Sanofi Consumer Healthcare India Limited | Sep 2026 | ▲ Increasing | +1,094 |
| Windlas Biotech Limited | Sep 2026 | ▼ Reducing | -463 |
| Viyash Scientific Limited | Aug 2026 | ▼ Reducing | -0.02 Cr |
| Manipal Health Enterprises Limited | Aug 2026 | ▲ New position | +0.02 Cr |
| Jupiter Life Line Hospitals Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Marksans Pharma Limited | Aug 2026 | ▼ Reducing | -0.01 Cr |
| Krishna Institute of Medical Sciences Limited | Aug 2026 | ▼ Complete exit | -0.01 Cr |
| Sudeep Pharma Limited | Aug 2026 | ▼ Reducing | -95,791 |
| Max Healthcare Institute Limited | Aug 2026 | ▲ Increasing | +85,031 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +83,143 |
| Laxmi Dental Limited | Aug 2026 | ▲ Increasing | +67,219 |
| Sai Life Sciences Limited | Aug 2026 | ▼ Reducing | -52,158 |
| Caplin Point Laboratories Limited | Aug 2026 | ▼ Reducing | -40,181 |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +35,841 |
| Rainbow Childrens Medicare Limited | Aug 2026 | ▲ Increasing | +20,000 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +16,850 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +15,170 |
| Gland Pharma Limited | Aug 2026 | ▼ Reducing | -10,000 |
| Biocon Limited | Jul 2026 | ▲ Increasing | +0.03 Cr |
| Blue Jet Healthcare Limited | Jul 2026 | ▲ New position | +0.02 Cr |
| Marksans Pharma Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▲ Increasing | +80,000 |
| Laxmi Dental Limited | Jul 2026 | ▲ Increasing | +61,276 |
| Fortis Healthcare Limited | Jul 2026 | ▼ Reducing | -25,000 |
| Gland Pharma Limited | Jul 2026 | ▼ Reducing | -20,251 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▲ Increasing | +20,205 |
| Rainbow Childrens Medicare Limited | Jul 2026 | ▲ Increasing | +19,729 |
| Viyash Scientific Limited | Jul 2026 | ▼ Reducing | -18,656 |
| Caplin Point Laboratories Limited | Jul 2026 | ▲ Increasing | +15,000 |
| Global Health Limited | Jul 2026 | ▲ Increasing | +14,290 |
| Ajanta Pharma Limited | Jul 2026 | ▼ Reducing | -4,021 |
| Krishna Institute of Medical Sciences Limited | Jul 2026 | ▼ Reducing | -2,679 |
| Divi's Laboratories Limited | Jul 2026 | ▲ Increasing | +465 |
| Aster DM Quality Care Limited | Jul 2026 | ▼ Reducing | -314 |
| Sudeep Pharma Limited | Jul 2026 | ▼ Reducing | -4 |
| Marksans Pharma Limited | Jun 2026 | ▼ Reducing | -0.01 Cr |
| Krishna Institute of Medical Sciences Limited | Jun 2026 | ▼ Reducing | -90,137 |
| Anthem Biosciences Limited | Jun 2026 | ▲ Increasing | +49,728 |
| Rainbow Childrens Medicare Limited | Jun 2026 | ▲ Increasing | +46,109 |
| Alembic Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +31,377 |
| Global Health Limited | Jun 2026 | ▲ Increasing | +30,000 |
| Windlas Biotech Limited | Jun 2026 | ▲ Increasing | +17,590 |
| IPCA Laboratories Limited | Jun 2026 | ▲ Increasing | +17,026 |
| Sudeep Pharma Limited | Jun 2026 | ▼ Reducing | -16,573 |
| Caplin Point Laboratories Limited | Jun 2026 | ▲ Increasing | +15,000 |
| Alkem Laboratories Limited | Jun 2026 | ▲ Increasing | +5,830 |
| Divi's Laboratories Limited | Jun 2026 | ▲ Increasing | +5,428 |
| Pfizer Limited | Jun 2026 | ▼ Reducing | -1,442 |
| Ajanta Pharma Limited | Jun 2026 | ▼ Reducing | -1,274 |
| Laxmi Dental Limited | Jun 2026 | ▲ Increasing | +58 |
| Alembic Pharmaceuticals Limited | May 2026 | ▲ Increasing | +65,933 |
| Aurobindo Pharma Limited | May 2026 | ▼ Reducing | -42,204 |
| Ajanta Pharma Limited | May 2026 | ▼ Reducing | -41,216 |
| Caplin Point Laboratories Limited | May 2026 | ▲ Increasing | +39,847 |
| Sudeep Pharma Limited | May 2026 | ▼ Reducing | -39,549 |
| Laxmi Dental Limited | May 2026 | ▲ Increasing | +35,137 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▼ Reducing | -29,882 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +29,443 |
| Divi's Laboratories Limited | May 2026 | ▲ Increasing | +28,076 |
| Acutaas Chemicals Limited | May 2026 | ▼ Complete exit | -25,000 |
| Global Health Limited | May 2026 | ▲ Increasing | +19,272 |
| Lupin Limited | May 2026 | ▼ Reducing | -6,166 |
| Windlas Biotech Limited | May 2026 | ▲ Increasing | +3,324 |
| Orchid Pharma Limited | May 2026 | ▲ Increasing | +1,402 |
| Cohance Lifesciences Limited | Apr 2026 | ▼ Reducing | -0.03 Cr |
| Laxmi Dental Limited | Apr 2026 | ▲ Increasing | +0.02 Cr |
| Lupin Limited | Apr 2026 | ▼ Reducing | -60,000 |
| Sudeep Pharma Limited | Apr 2026 | ▼ Reducing | -58,509 |
| Max Healthcare Institute Limited | Apr 2026 | ▲ Increasing | +56,416 |
| Glenmark Pharmaceuticals Limited | Apr 2026 | ▼ Reducing | -40,560 |
| Aurobindo Pharma Limited | Apr 2026 | ▼ Reducing | -39,091 |
| Alembic Pharmaceuticals Limited | Apr 2026 | ▲ Increasing | +20,217 |
| Syngene International Limited | Apr 2026 | ▼ Reducing | -16,868 |
| Eris Lifesciences Limited | Apr 2026 | ▼ Reducing | -15,000 |
| IPCA Laboratories Limited | Apr 2026 | ▲ Increasing | +6,401 |
| Ajanta Pharma Limited | Apr 2026 | ▼ Reducing | -4,345 |
| Pfizer Limited | Apr 2026 | ▼ Reducing | -2,617 |
| Viyash Scientific Limited | Apr 2026 | ▼ Reducing | -303 |
| Caplin Point Laboratories Limited | Apr 2026 | ▲ Increasing | +153 |
| Laxmi Dental Limited | Mar 2026 | ▲ Increasing | +0.03 Cr |
| Marksans Pharma Limited | Mar 2026 | ▲ Increasing | +86,431 |
| Anthem Biosciences Limited | Mar 2026 | ▲ Increasing | +71,716 |
Changes compare consecutive month-end disclosures for this portfolio only.